BMRN Dividend History & Analysis | N/A Yield
BMRN has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,434 M | 13.5% | 7.37% |
| ABBV | 393,809 M | 3.60% | 9.74% |
| GILD | 150,721 M | 2.53% | 6.73% |
| AMGN | 174,694 M | 2.86% | 4.98% |
| HLN | 44,084 M | 1.74% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,434 M | 203% | 90.0% |
| GRFS | 7,645 M | 127% | 56.8% |
| HLN | 44,084 M | 51.0% | 100% |
| AMGN | 174,694 M | 8.90% | 100% |
| ABBV | 393,809 M | 7.06% | 100% |
Similar Stocks with Attractive Dividends - Compare BMRN Dividends with its Peer-Group
3.60% Yield
2.86% Yield
2.53% Yield
1.74% Yield
BMRN Dividend History: as of December 2025
No dividends paid yet.BMRN Dividend FAQ
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a U.S.-based biotech that develops and commercializes therapies for rare, life-threatening diseases across North America, Europe, Latin America, the Middle East, and the Asia-Pacific. Its approved portfolio includes VIMIZIM (MPS IV A), VOXZOGO (achondroplasia), NAGLAZYME (MPS VI), PALYNZIQ (phenylketonuria), BRINEURA (Batten disease), ALDURAZYME (MPS I), KUVAN (PKU), and ROCTAVIAN (severe hemophilia A). The company also maintains a pipeline of next-generation products such as BMN 333 (long-acting CNP for growth disorders), BMN 349 (oral therapy for alpha-1 antitrypsin deficiency–related liver disease), and BMN 351 (oligonucleotide for Duchenne muscular dystrophy). Distribution is handled through specialty pharmacies, hospitals, government agencies, and wholesale partners, and BioMarin leverages collaborations with Catalyst Pharmaceutical Partners and Ares Trading.
What is the Dividend Yield of BMRN?
As of December 2025, BMRN`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 59.95.Does BMRN pay a dividend?
As of December 2025 BMRN does not pay a dividend.How often does BMRN pay dividends?
Over the last 12 months, BMRN has issued dividend payments.BMRN dividend forecast
Based on historical data, the forecasted dividends per share for BMRN for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will BMRN pay dividends in 2025?
The next Ex-Dividend date for Biomarin Pharmaceutical (BMRN) is currently unknown.What is the next Ex-Dividend Date for BMRN?
The next Ex-Dividend date for Biomarin Pharmaceutical (BMRN) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of BMRN?
BMRN's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of BMRN?
BMRN's 5-Year Yield on Cost is -%. If you bought BMRN's shares at 87.58 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of BMRN?
BMRN Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does BMRN have a good Dividend Yield?
BMRN`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of BMRN?
The Dividend Payout Ratio of BMRN is unknown.What is the Dividend Rating of BMRN?
BMRN`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-12 02:38